Show simple item record

dc.contributor.authorStoen, Maria J.
dc.contributor.authorAndersen, Sigve
dc.contributor.authorRakaee, Mehrdad
dc.contributor.authorPedersen, Mona I.
dc.contributor.authorIngebriktsen, Lise M.
dc.contributor.authorDønnem, Tom
dc.contributor.authorLombardi, Ana P. G.
dc.contributor.authorKilvaer, Thomas K.
dc.contributor.authorRasmussen Busund, Lill-Tove
dc.contributor.authorRichardsen, Elin
dc.date.accessioned2021-09-10T13:14:38Z
dc.date.available2021-09-10T13:14:38Z
dc.date.created2021-08-30T17:38:16Z
dc.date.issued2021
dc.identifier.issn2072-6694
dc.identifier.urihttps://hdl.handle.net/11250/2775250
dc.description.abstractObjective: assessing the prognostic role of miR-20a-5p, in terms of clinical outcome, in a large multi-institutional cohort study. Methods: Tissue microarrays from 535 patients’ prostatectomy specimens were constructed. In situ hybridization was performed to assess the expression level of miR-20a-5p in different tissue subregions: tumor stroma (TS) and tumor epithelium (TE). In vitro analysis was performed on prostate cancer cell lines. Results: A high miR-20a-5p expression was found negatively in association with biochemical failure in TE, TS and TE + TS (p = 0.001, p = 0.003 and p = 0.001, respectively). Multivariable analysis confirmed that high miR-20a-5p expression in TE independently predicts dismal prognosis for biochemical failure (HR = 1.56, 95% CI: 1.10–2.21, p = 0.014). Both DU145 and PC3 cells exhibited increased migration ability after transient overexpression of miR-20a-5p, as well as significant elevation of invasion in DU145 cells. Conclusion: A high miR-20a-5p expression in tumor epithelium is an independent negative predictor for biochemical prostate cancer recurrence.en_US
dc.language.isoengen_US
dc.publisherMDPIen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleOverexpression of mir-20a-5p in tumor epithelium is an independent negative prognostic indicator in prostate cancer—a multi-institutional studyen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2021 the authorsen_US
dc.source.articlenumber4096en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doi10.3390/cancers13164096
dc.identifier.cristin1929866
dc.source.journalCancersen_US
dc.identifier.citationCancers. 2021, 13 (16), 4096.en_US
dc.source.volume13en_US
dc.source.issue16en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Navngivelse 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse 4.0 Internasjonal